Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab

References

• Heng DYC, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: Results from a large, multicenter study. J Clin Oncol. 2009;27(34):5794–5799.
   PubMed Web of Science ®Google Scholar
• Fujiwara R, Inamura K, Yuasa T, Numao N, Yamamoto S, Masuda H, Kawauchi A, Takeuchi K, Yonese J. Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer. Int J Clin Oncol. 2020;25(1):151–157.
   PubMed Web of Science ®Google Scholar
• Kwon W-A, Kim S, Kim SH, Joung JY, Seo HK, Lee KH, Chung J. Pretreatment prognostic nutritional index is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with targeted therapy. Clin Genitourin Cancer. 2017;15(1):100–111.
   PubMed Web of Science ®Google Scholar
• Takemura K, Yuasa T, Fujiwara R, Ito M, Suzuki H, Yonese J, Koga F. Prognostic significance of the Controlling Nutritional Status (CONUT) score in patients with advanced renal cell carcinoma treated with nivolumab after failure of prior tyrosine kinase inhibitors. J Urol. 2020;204(6):1166–1172.
   PubMed Web of Science ®Google Scholar
• Okita K, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, et al. Impact of disagreement between two risk group models on prognosis in patients with metastatic renal-cell carcinoma. Clin Genitourin Cancer. 2019;17(3):e440–e446.
   PubMed Web of Science ®Google Scholar
• Chang LW, Hung SC, Li JR, Chiu KY, Yang CK, Chen CS, Lu K, Chen CC, Wang SC, Lin CY, et al. Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel. Front Pharmacol. 2021;25(11):601513.
   Web of Science ®Google Scholar
• Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803–1813.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Kitano S, Takahashi A, Tsutsumida A, Namikawa K, Tanese K, Abe T, Funakoshi T, Yamamoto N, Amagai M, et al. Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy. Oncotarget. 2016;7(47):77404–77415.
   PubMedGoogle Scholar
• Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent J-P, Nicolis I, Benazeth S, Cynober L, Aussel C. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777–783.
   PubMed Web of Science ®Google Scholar
• Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008;87(1):106–113.
   PubMed Web of Science ®Google Scholar
• Cereda E, Pusani C, Limonta D, Vanotti A. The ability of the Geriatric Nutritional Risk Index to assess the nutritional status and predict the outcome of home-care resident elderly: a comparison with the Mini Nutritional Assessment. Br J Nutr. 2009;102(4):563–570.
   PubMed Web of Science ®Google Scholar
• Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, et al. Validation of the IMDC prognostic model in patients with metastatic renal-cell carcinoma treated with first-line axitinib: a multicenter retrospective study. Clin Genitourin Cancer. 2019;17(5):e1080–e1089.
   PubMed Web of Science ®Google Scholar
• Fujiwara R, Takemura K, Fujiwara M, Yuasa T, Yasuoka S, Komai Y, Numao N, Yamamoto S, Yonese J. Modified Glasgow Prognostic Score as a predictor of prognosis in metastatic renal cell carcinoma treated with nivolumab. Clin Genitourin Cancer. 2021;19(2):e78–e83.
   PubMed Web of Science ®Google Scholar
• Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J Urol. 2016;195(1):26–32.
   PubMed Web of Science ®Google Scholar
• Lee J, Suh J, Song C, You D, Jeong IG, Hong B, Hong JH, Kim CS, Ahn H. Association between sarcopenia and survival of patients with organ-confined renal cell carcinoma after radical nephrectomy. Ann Surg Oncol. 2022;29(4):2473–2479.
   PubMed Web of Science ®Google Scholar
• Auclin E, Bourillon C, De Maio E, By MA, Seddik S, Fournier L, Auvray M, Dautruche A, Vano Y-A, Thibault C, et al. Prediction of everolimus toxicity and prognostic value of skeletal muscle index in patients with metastatic renal cell carcinoma. Clin Genitourin Cancer. 2017;15(3):350–355.
   PubMed Web of Science ®Google Scholar
• Robinson S, Cooper C, Aihie Sayer A. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. J Aging Res. 2012;2012:510801.
   PubMedGoogle Scholar
• Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799.
   PubMed Web of Science ®Google Scholar
• Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Murai M, et al. Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology. 2007;69(1):113–117.
   PubMed Web of Science ®Google Scholar
• Matsukuma Y, Tanaka S, Taniguchi M, Nakano T, Masutani K, Hirakata H, Kitazono T, Tsuruya K. Association of geriatric nutritional risk index with infection-related mortality in patients undergoing hemodialysis: the Q-Cohort Study. Clin Nutr. 2019;38(1):279–287.
   PubMed Web of Science ®Google Scholar
• Kang HW, Seo SP, Kim WT, Yun SJ, Lee S-C, Kim W-J, Hwang EC, Kang SH, Hong S-H, Chung J, et al. A low Geriatric Nutritional Risk Index is associated with aggressive pathologic characteristics and poor survival after nephrectomy in clear renal cell carcinoma: a multicenter retrospective study. Nutr Cancer. 2020;72(1):88–97.
   PubMed Web of Science ®Google Scholar
• Gu W, Zhang G, Sun L, Ma Q, Cheng Y, Zhang H, Shi G, Zhu Y, Ye D. Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma. J Cachexia Sarcopenia Muscle. 2015;6(3):222–230.
   PubMed Web of Science ®Google Scholar
• Karayama M, Inoue Y, Yoshimura K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, et al. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small cell lung cancer after nivolumab therapy. J Immunother. 2022;45(2):125–131.
   PubMed Web of Science ®Google Scholar
• Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F, Giusti R, Tiseo M, Michiara M, Di Marino P, et al. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable. J Immunother Cancer. 2019;7(1):57.
   PubMed Web of Science ®Google Scholar
• Herrmann T, Mione C, Montoriol P-F, Molnar I, Ginzac A, Durando X, Mahammedi H. Body mass index, sarcopenia, and their variations in predicting outcomes for patients treated with nivolumab for metastatic renal cell carcinoma. Oncology. 2022;100(2):114–123.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.
   PubMed Web of Science ®Google Scholar
• Jordan BF, Gourgue F, Cani PD. Adipose tissue metabolism and cancer progression: novel insights from gut microbiota? Curr Pathobiol Rep. 2017;5(4):315–322.
   PubMedGoogle Scholar
• Magrone T, Jirillo E. Childhood obesity: immune response and nutritional approaches. Front Immunol. 2015;6:76.
   PubMed Web of Science ®Google Scholar
• Seijkens T, Kusters P, Chatzigeorgiou A, Chavakis T, Lutgens E. Immune cell crosstalk in obesity: a key role for costimulation? Diabetes. 2014;63(12):3982–3991.
   PubMed Web of Science ®Google Scholar
• Zhou X, Fu G, Zu X, Xu Z, Li H-T, D'souza A, Tulpule V, Quinn DI, Bhowmick NA, Weisenberger DJ, et al. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis. Urol Oncol. 2022;40(1):12.e13–12.e22.
   PubMed Web of Science ®Google Scholar
• Yoshino M, Ishihara H, Ishiyama Y, Tachibana H, Toki D, Yamashita K, Kobayashi H, Fukuda H, Yoshida K, Takagi T, et al. Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. In Vivo. 2021;35(5):2855–2862.
   PubMed Web of Science ®Google Scholar
• Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers (Basel). 2021;13(17):4495.
   PubMed Web of Science ®Google Scholar
• Neubert E, Senger-Sander SN, Manzke VS, Busse J, Polo E, Scheidmann SEF, Schön MP, Kruss S, Erpenbeck L. Serum and serum albumin inhibit in vitro formation of neutrophil extracellular traps (NETs). Front Immunol. 2019;10:12.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20(1):289–296.
   PubMed Web of Science ®Google Scholar
• Ito T, Mizutani K, Takahara K, Ando R, Yasui T, Shiroki R, Koie T, Miyake H. Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: an observational multi-institute study. Mol Clin Oncol. 2022;16(1):17.
   PubMed Web of Science ®Google Scholar